Cytomx Therapeutics, Inc. · NASDAQ:CTMX

FMR LLC reported a 14.60% stake in Cytomx Therapeutics, Inc. (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 5, 2026

FMR LLC reported a 14.60% stake in Cytomx Therapeutics, Inc., 24,688,109 shares, as a passive investor on Dec 31, 2025. Filed Feb 5, 2026 (Schedule 13G/A).

Stake
14.60%
Shares
24,688,109
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
FMR LLC14.60%24,688,109
Abigail P. Johnson14.60%24,688,109

Source

View original at SEC

Related